HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage TropismMichael Roche, Paul R. Gorry, Melissa J. Churchill et al.|Journal of Virology|2011Cited by 82
Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C InfectionMartin R. Jakobsen, Paul R. Gorry, Kieran Cashin et al.|PLoS ONE|2013Cited by 48
CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithmKieran Cashin, Paul R. Gorry, Lachlan Gray et al.|Retrovirology|2013Cited by 30
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitrousage of alternative coreceptors during progressive HIV-1 subtype C infectionKieran Cashin, Paul R. Gorry, Jasminka Sterjovski et al.|Retrovirology|2013Cited by 22
Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infectionJessica Wade, Paul R. Gorry, Jasminka Sterjovski et al.|Virology|2009Cited by 20